Omar Abdihamid
Research Subjects
Omar Abdihamid has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Fatuma Affey
3 shared publications- Nazik Hammad
Division of Hematology-Oncology, St Michael's Hospital, University of Toronto, Toronto, Canada
3 shared publications Abeid Omar
Kenyatta University Teaching Research and Referral Hospital, PO Box 7674 - 00100, GPO Nairobi, Kenya
2 shared publications- Dario Trapani
European Institute of Oncology, IRCCS, Milan, Italy
2 shared publications Fidel Rubagumya
Rwanda Military Hospital, Kigali, Rwanda
2 shared publicationsJamal Saman
2 shared publications
Latest Publications
- 1 October 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (10)
Pivotal Role of Environmental Protection Agencies in Global Cancer Control
- 1 October 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (10)
Pivotal Role of Environmental Protection Agencies in Global Cancer Control
- Open Access
- 11 June 2026
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 20
Baseline knowledge, attitudes and perceptions on the oncology profession among final-year medical students in Kenya: a cross-sectional study
Kenya faces a rising cancer burden amid a critical shortage of oncology professionals. Undergraduate exposure, knowledge and attitudes shape specialty choices, yet local evidence remains scarce. This study assessed baseline knowledge, attitudes and perceptions of oncology among final-year medical students in Kenya to inform curriculum development, mentorship and workforce planning. A descriptive cross-sectional online survey was conducted among final-year Bachelor of Medicine and Bachelor of Surgery students across accredited Kenyan medical schools between April and May 2025. A structured Qualtrics questionnaire assessed sociodemographics, career intentions, oncology knowledge and exposure and attitudes toward oncology. Data were analysed using descriptive statistics. Participation was voluntary and anonymous. Ethical approval was obtained from the Mount Kenya University Ethics Review Committee (MKU/ISERC/5342). Of 89 responses, 88 were analysed. Participants were equally male and female (50% each), with a mean age of 25 years. Most respondents were from the University of Nairobi (73%), followed by Moi University (17%) and other institutions. Seventy-seven percent reported a close friend or relative diagnosed with cancer. Community responses were mainly supportive (60%), though 32% viewed cancer as a ‘death sentence’ and 8% reported stigma or avoidance. Personal or family experience shaped perceptions for 61% and 81% cited cultural beliefs as influencing community reactions. Seventy-three percent had completed an oncology rotation, but only 30% attended oncology-focused workshops. Over half (53%) were unsure of cancer incidence in Kenya. Chemotherapy and radiotherapy were the most recognised treatments, with limited awareness of immunotherapy. Eighty-six percent agreed that oncology training should be strengthened. While 84% knew oncology is a recognised specialty in Kenya, only 42% were aware of local postgraduate programs. Most rated the undergraduate oncology curriculum as ‘average’ (42%). Twenty-five percent would consider oncology as a career, 51% were undecided and 24% would not. Motivators included clinical exposure and patient outcomes; deterrents were emotional burden, lack of mentorship, patient suffering and poor work–life balance. Suggested strategies included increased clinical exposure, structured mentorship, expanded residency slots and targeted incentives. Final-year Kenyan medical students acknowledge oncology as a career but face significant knowledge and exposure gaps. Strengthening undergraduate oncology education, expanding mentorship opportunities and creating clear postgraduate pathways are key to building a robust, homegrown oncology workforce in Kenya.
- 11 June 2026
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 20
Open AccessBaseline knowledge, attitudes and perceptions on the oncology profession among final-year medical students in Kenya: a cross-sectional study
Kenya faces a rising cancer burden amid a critical shortage of oncology professionals. Undergraduate exposure, knowledge and attitudes shape specialty choices, yet local evidence remains scarce. This study assessed baseline knowledge, attitudes and perceptions of oncology among final-year medical students in Kenya to inform curriculum development, mentorship and workforce planning. A descriptive cross-sectional online survey was conducted among final-year Bachelor of Medicine and Bachelor of Surgery students across accredited Kenyan medical schools between April and May 2025. A structured Qualtrics questionnaire assessed sociodemographics, career intentions, oncology knowledge and exposure and attitudes toward oncology. Data were analysed using descriptive statistics. Participation was voluntary and anonymous. Ethical approval was obtained from the Mount Kenya University Ethics Review Committee (MKU/ISERC/5342). Of 89 responses, 88 were analysed. Participants were equally male and female (50% each), with a mean age of 25 years. Most respondents were from the University of Nairobi (73%), followed by Moi University (17%) and other institutions. Seventy-seven percent reported a close friend or relative diagnosed with cancer. Community responses were mainly supportive (60%), though 32% viewed cancer as a ‘death sentence’ and 8% reported stigma or avoidance. Personal or family experience shaped perceptions for 61% and 81% cited cultural beliefs as influencing community reactions. Seventy-three percent had completed an oncology rotation, but only 30% attended oncology-focused workshops. Over half (53%) were unsure of cancer incidence in Kenya. Chemotherapy and radiotherapy were the most recognised treatments, with limited awareness of immunotherapy. Eighty-six percent agreed that oncology training should be strengthened. While 84% knew oncology is a recognised specialty in Kenya, only 42% were aware of local postgraduate programs. Most rated the undergraduate oncology curriculum as ‘average’ (42%). Twenty-five percent would consider oncology as a career, 51% were undecided and 24% would not. Motivators included clinical exposure and patient outcomes; deterrents were emotional burden, lack of mentorship, patient suffering and poor work–life balance. Suggested strategies included increased clinical exposure, structured mentorship, expanded residency slots and targeted incentives. Final-year Kenyan medical students acknowledge oncology as a career but face significant knowledge and exposure gaps. Strengthening undergraduate oncology education, expanding mentorship opportunities and creating clear postgraduate pathways are key to building a robust, homegrown oncology workforce in Kenya.
- 1 June 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (6) , e70487
Strengthening Informal Cancer Caregiving in Kenya's Health System: Challenges and Support Strategies at Machakos County Referral Hospital
Background: Cancer care is complex, prolonged, and resource‐intensive, often placing significant physical, emotional, and financial burdens on informal cancer caregivers. In Kenya, as cancer treatment services expand, the responsibility of caregiving increasingly shifts to family members. However, their needs remain largely unaddressed within the healthcare system. Aim: To assess the challenges faced by informal caregivers of cancer patients at Machakos County Referral Hospital (MCRH) and propose context‐specific support strategies. Methods: A descriptive cross‐sectional design was conducted over 1 month was conducted over 1 month (from 5 th June to 6 th July 2024) among informal caregivers of patients undergoing cancer treatment for over 3 months at the MCRH. Eligible informal caregivers ( n = 74) were randomly selected from a sampling frame derived from hospital cancer treatment registers, with randomization used to minimize selection bias. Data were collected through semi‐structured, interviewer‐administered questionnaires and analyzed using SPSS version 25. Results: The response rate was 92% ( n = 68/74). The mean caregiver age was 46.1 years; most were female (60.8%, n = 45/74), married (75.7%, n = 56/74), and unemployed (56.7%, n = 42/74). Financial constraints were the most reported challenge (56.7%, n = 42/74), followed by delayed diagnosis (43.2%, n = 32/74), caregiver fatigue (30.4% n = 24/74), psychological exhaustion (29.7% n = 22/74), sleep disturbances (28.3% n = 21/74), distress related to prognosis (25.6% n = 19/74), and limited knowledge on symptom management (21.6% n = 16/74). Most patients were diagnosed with breast cancer, 40.5% ( n = 30/74), with most of all cancers being diagnosed at stage II, 36.4% ( n = 27/74), and the majority receiving only chemotherapy, 24.3% ( n = 18/74). Conclusion: Caregivers experience significant socioeconomic and psychological strain. There is an urgent need for formal caregiver support programs, targeted education, psychosocial services, and linkages to financial and community resources. Two feasible actions at MCRH include: integrating a brief caregiver needs screening tool and monthly caregiver education sessions into oncology clinic visits, and establishing a clear referral pathway to social work, insurance navigation, and vetted donor/community support. Strengthening caregiver support is critical to improving caregiver well‐being and the overall quality of cancer care.
- 1 June 2026
- Published by Wiley in Psycho-Oncology
- Vol. 35 (6) , e70487
Strengthening Informal Cancer Caregiving in Kenya's Health System: Challenges and Support Strategies at Machakos County Referral Hospital
Background: Cancer care is complex, prolonged, and resource‐intensive, often placing significant physical, emotional, and financial burdens on informal cancer caregivers. In Kenya, as cancer treatment services expand, the responsibility of caregiving increasingly shifts to family members. However, their needs remain largely unaddressed within the healthcare system. Aim: To assess the challenges faced by informal caregivers of cancer patients at Machakos County Referral Hospital (MCRH) and propose context‐specific support strategies. Methods: A descriptive cross‐sectional design was conducted over 1 month was conducted over 1 month (from 5 th June to 6 th July 2024) among informal caregivers of patients undergoing cancer treatment for over 3 months at the MCRH. Eligible informal caregivers ( n = 74) were randomly selected from a sampling frame derived from hospital cancer treatment registers, with randomization used to minimize selection bias. Data were collected through semi‐structured, interviewer‐administered questionnaires and analyzed using SPSS version 25. Results: The response rate was 92% ( n = 68/74). The mean caregiver age was 46.1 years; most were female (60.8%, n = 45/74), married (75.7%, n = 56/74), and unemployed (56.7%, n = 42/74). Financial constraints were the most reported challenge (56.7%, n = 42/74), followed by delayed diagnosis (43.2%, n = 32/74), caregiver fatigue (30.4% n = 24/74), psychological exhaustion (29.7% n = 22/74), sleep disturbances (28.3% n = 21/74), distress related to prognosis (25.6% n = 19/74), and limited knowledge on symptom management (21.6% n = 16/74). Most patients were diagnosed with breast cancer, 40.5% ( n = 30/74), with most of all cancers being diagnosed at stage II, 36.4% ( n = 27/74), and the majority receiving only chemotherapy, 24.3% ( n = 18/74). Conclusion: Caregivers experience significant socioeconomic and psychological strain. There is an urgent need for formal caregiver support programs, targeted education, psychosocial services, and linkages to financial and community resources. Two feasible actions at MCRH include: integrating a brief caregiver needs screening tool and monthly caregiver education sessions into oncology clinic visits, and establishing a clear referral pathway to social work, insurance navigation, and vetted donor/community support. Strengthening caregiver support is critical to improving caregiver well‐being and the overall quality of cancer care.
- Open Access
Burden of Cancer in Kilifi County: A 10-Year Retrospective Descriptive Study
Background: Cancer is an increasing public health challenge in Kenya, particularly in rural and underserved regions where surveillance systems and diagnostic capacity remain limited. Kilifi County, located along the Kenyan coast, lacks a population-based cancer registry, and data on the local cancer burden is not available. This study aimed to characterize the demographic distribution of patients, cancer burden in the county, and management of cancer cases diagnosed at Kilifi County Referral Hospital (KCRH) over ten years. Methods: This retrospective study analyzed the patterns of cancer in Kilifi County using patient records from KCRH during the study period (January 1, 2014, to January 1, 2024). Results: A total of 101 patients with cancer were identified, 58% female, with a mean age of 54 years. Most patients were from Kilifi North (47%), with a high proportion reporting no formal occupation (41%) or farming (26%). Esophageal and cervical cancers were the most common (18% each), followed by breast and prostate cancers (5% each), with other malignancies occurring infrequently. Histopathology was the primary diagnostic modality (88%). Staging data were incomplete in 70% of cases; among documented cases, the majority presented with advanced disease (21% stage IV). Due to limited local treatment capacity, approximately half of the patients were referred to tertiary centers for chemotherapy, radiotherapy, or surgery. At data cut-off, 43% had died, 25% were on treatment, and 29% were lost to follow-up, with only 2% completing treatment or under follow-up. Conclusions: This study demonstrates a substantial cancer burden in Kilifi County and highlights critical gaps in diagnostic capacity, staging, and continuity of care. Strengthening cancer surveillance systems, expanding diagnostic and treatment infrastructure, and establishing a population-based cancer registry are essential to improving cancer outcomes and advancing equitable care in rural Kenya
Open AccessBurden of Cancer in Kilifi County: A 10-Year Retrospective Descriptive Study
Background: Cancer is an increasing public health challenge in Kenya, particularly in rural and underserved regions where surveillance systems and diagnostic capacity remain limited. Kilifi County, located along the Kenyan coast, lacks a population-based cancer registry, and data on the local cancer burden is not available. This study aimed to characterize the demographic distribution of patients, cancer burden in the county, and management of cancer cases diagnosed at Kilifi County Referral Hospital (KCRH) over ten years. Methods: This retrospective study analyzed the patterns of cancer in Kilifi County using patient records from KCRH during the study period (January 1, 2014, to January 1, 2024). Results: A total of 101 patients with cancer were identified, 58% female, with a mean age of 54 years. Most patients were from Kilifi North (47%), with a high proportion reporting no formal occupation (41%) or farming (26%). Esophageal and cervical cancers were the most common (18% each), followed by breast and prostate cancers (5% each), with other malignancies occurring infrequently. Histopathology was the primary diagnostic modality (88%). Staging data were incomplete in 70% of cases; among documented cases, the majority presented with advanced disease (21% stage IV). Due to limited local treatment capacity, approximately half of the patients were referred to tertiary centers for chemotherapy, radiotherapy, or surgery. At data cut-off, 43% had died, 25% were on treatment, and 29% were lost to follow-up, with only 2% completing treatment or under follow-up. Conclusions: This study demonstrates a substantial cancer burden in Kilifi County and highlights critical gaps in diagnostic capacity, staging, and continuity of care. Strengthening cancer surveillance systems, expanding diagnostic and treatment infrastructure, and establishing a population-based cancer registry are essential to improving cancer outcomes and advancing equitable care in rural Kenya
- 1 June 2026
- Published by American Society of Clinical Oncology (ASCO) in American Society of Clinical Oncology Educational Book
- Vol. 46 (3) , e521198
Global Disparities in Cancer Care for Conflict-Affected Populations: Africa's Neglected Crisis
Cancer care in conflict-affected settings represents a growing yet underrecognized global health crisis, disproportionately affecting populations in low- and middle-income countries, particularly in Africa. With over 130 million people forcibly displaced worldwide, conflict-driven disruptions to health systems have created profound gaps across the cancer care continuum, from prevention and diagnosis to treatment and palliative care. In these settings, cancer is often deprioritized in favor of acute and communicable diseases, resulting in delayed diagnosis, treatment interruptions, and poor outcomes. This review examines the impact of conflict on cancer care delivery, highlighting structural disruptions, including infrastructure destruction, workforce displacement, and supply chain collapse. Drawing on case studies from Sudan, Somalia, Burkina Faso, and Kenya, it presents exploratory, field-informed strategies to sustain care. In Sudan, telehealth, primarily through WhatsApp and mobile communication, has enabled continuity of care, real-time triage, and cross-border clinical collaboration despite severe connectivity challenges, supported by emerging hybrid digital platforms. In Burkina Faso, the collapse of surgical oncology capacity has led to predominantly late-stage, palliative interventions; however, adaptive responses such as mobile clinics, tele-oncology, and decentralized service delivery have partially mitigated these gaps. The manuscript further emphasizes the potential role of mobile oncology units in delivering cancer medicines, basic surgical care, and palliative services, alongside context-adapted training for health care workers in crisis settings. It highlights the need for coordinated safe cross-border referral systems, interoperable digital health platforms, and the establishment of safe humanitarian corridors for patient transfer. Addressing cancer care in conflict settings requires integrating oncology into humanitarian responses, strengthening decentralized and resilient systems, and fostering regional collaboration to ensure equitable access for vulnerable populations.
- 1 June 2026
- Published by American Society of Clinical Oncology (ASCO) in American Society of Clinical Oncology Educational Book
- Vol. 46 (3) , e521198
Global Disparities in Cancer Care for Conflict-Affected Populations: Africa's Neglected Crisis
Cancer care in conflict-affected settings represents a growing yet underrecognized global health crisis, disproportionately affecting populations in low- and middle-income countries, particularly in Africa. With over 130 million people forcibly displaced worldwide, conflict-driven disruptions to health systems have created profound gaps across the cancer care continuum, from prevention and diagnosis to treatment and palliative care. In these settings, cancer is often deprioritized in favor of acute and communicable diseases, resulting in delayed diagnosis, treatment interruptions, and poor outcomes. This review examines the impact of conflict on cancer care delivery, highlighting structural disruptions, including infrastructure destruction, workforce displacement, and supply chain collapse. Drawing on case studies from Sudan, Somalia, Burkina Faso, and Kenya, it presents exploratory, field-informed strategies to sustain care. In Sudan, telehealth, primarily through WhatsApp and mobile communication, has enabled continuity of care, real-time triage, and cross-border clinical collaboration despite severe connectivity challenges, supported by emerging hybrid digital platforms. In Burkina Faso, the collapse of surgical oncology capacity has led to predominantly late-stage, palliative interventions; however, adaptive responses such as mobile clinics, tele-oncology, and decentralized service delivery have partially mitigated these gaps. The manuscript further emphasizes the potential role of mobile oncology units in delivering cancer medicines, basic surgical care, and palliative services, alongside context-adapted training for health care workers in crisis settings. It highlights the need for coordinated safe cross-border referral systems, interoperable digital health platforms, and the establishment of safe humanitarian corridors for patient transfer. Addressing cancer care in conflict settings requires integrating oncology into humanitarian responses, strengthening decentralized and resilient systems, and fostering regional collaboration to ensure equitable access for vulnerable populations.
- 1 March 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (3) , e2500506
Esophageal Cancer in Somalia: Burden and Outcomes From a Multicenter Observational Study in Mogadishu
PURPOSE: Esophageal cancer (EC) remains a leading cause of cancer mortality worldwide, with East Africa forming a high-incidence EC belt. Despite Somalia's inclusion in this region, there are no cancer registries or outcome data. We conducted a multicenter observational study in Mogadishu to describe the burden, clinicopathologic characteristics, treatment patterns, referral pathways, and outcomes of EC. METHODS: We retrospectively reviewed records of patients (18 years and older) with histologically confirmed EC diagnosed between January 2022 and December 2024 in the two major diagnostic centers in Mogadishu. Demographic, clinical, pathologic, treatment, and referral data were extracted and analyzed descriptively. RESULTS: A total of 468 patients were included (mean age 55.9 years; 62% female). EC was the most common cancer diagnosed in both females and males. Dysphagia was the commonest symptom (56.8%). Squamous cell carcinoma accounted for 97.6%. Disease staging was poorly documented (>80% missing) although available data showed that most presented with advanced disease. Limited radiology capacity meant that diagnoses relied mainly on endoscopic biopsy. Hot tea consumption was the most recorded risk factor (48.9%). Treatment access was restricted: chemotherapy alone predominated (25.9%), whereas surgery (1.3%) and chemoradiotherapy (6.0%) were rare. Over one fifth (21.8%) received no treatment, and 44.2% was lost to follow-up. Of those cases with follow-up, 40.0% had died and 15.8% was alive. Referral analysis showed that 6.0% sought care in India, 0.6% in Ethiopia, 0.4% each in Kenya and Egypt, and 0.2% in Saudi Arabia, whereas 48.1% was managed locally and 43.8% had undocumented destinations. CONCLUSION: To our knowledge, this first multicenter study from Somalia reveals late-stage presentation, severe staging and treatment gaps, and poor survival. Strengthening diagnostic infrastructure, multidisciplinary care, and cancer registry systems is urgently needed to improve EC outcomes in Somalia.
- 1 March 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (3) , e2500506
Esophageal Cancer in Somalia: Burden and Outcomes From a Multicenter Observational Study in Mogadishu
PURPOSE: Esophageal cancer (EC) remains a leading cause of cancer mortality worldwide, with East Africa forming a high-incidence EC belt. Despite Somalia's inclusion in this region, there are no cancer registries or outcome data. We conducted a multicenter observational study in Mogadishu to describe the burden, clinicopathologic characteristics, treatment patterns, referral pathways, and outcomes of EC. METHODS: We retrospectively reviewed records of patients (18 years and older) with histologically confirmed EC diagnosed between January 2022 and December 2024 in the two major diagnostic centers in Mogadishu. Demographic, clinical, pathologic, treatment, and referral data were extracted and analyzed descriptively. RESULTS: A total of 468 patients were included (mean age 55.9 years; 62% female). EC was the most common cancer diagnosed in both females and males. Dysphagia was the commonest symptom (56.8%). Squamous cell carcinoma accounted for 97.6%. Disease staging was poorly documented (>80% missing) although available data showed that most presented with advanced disease. Limited radiology capacity meant that diagnoses relied mainly on endoscopic biopsy. Hot tea consumption was the most recorded risk factor (48.9%). Treatment access was restricted: chemotherapy alone predominated (25.9%), whereas surgery (1.3%) and chemoradiotherapy (6.0%) were rare. Over one fifth (21.8%) received no treatment, and 44.2% was lost to follow-up. Of those cases with follow-up, 40.0% had died and 15.8% was alive. Referral analysis showed that 6.0% sought care in India, 0.6% in Ethiopia, 0.4% each in Kenya and Egypt, and 0.2% in Saudi Arabia, whereas 48.1% was managed locally and 43.8% had undocumented destinations. CONCLUSION: To our knowledge, this first multicenter study from Somalia reveals late-stage presentation, severe staging and treatment gaps, and poor survival. Strengthening diagnostic infrastructure, multidisciplinary care, and cancer registry systems is urgently needed to improve EC outcomes in Somalia.
- Open Access
- 7 January 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (1) , e020895
The current state of oncological emergency services in Kenya: challenges and opportunities
Cancer remains a leading cause of morbidity and mortality in Kenya, with the healthcare system increasingly challenged by oncologic emergencies (OEs)—acute, life-threatening complications that require immediate intervention. Although Kenya has advanced in decentralising cancer care through regional centres and expanding access to chemotherapy, radiotherapy and palliative care, a critical gap persists in the recognition and management of OEs. Conditions such as spinal cord compression, febrile neutropenia, tumour lysis syndrome and superior vena cava obstruction are common but often underdiagnosed or inadequately managed in acute settings. Poor outcomes are largely driven by workforce shortages, weak triage systems, financial toxicity and limited provider training. This paper calls for a national strategy to integrate OEs management into cancer centres and emergency departments through standardised clinical guidelines, capacity building, improved referral networks and inclusion in health insurance coverage. Strengthening infrastructure, workforce education and longitudinal research on OEs patterns will be essential to improving outcomes. A timely, coordinated response to OEs can substantially enhance survival, reduce complications and promote equitable access to life-saving care across Kenya.
- 7 January 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (1) , e020895
Open AccessThe current state of oncological emergency services in Kenya: challenges and opportunities
Cancer remains a leading cause of morbidity and mortality in Kenya, with the healthcare system increasingly challenged by oncologic emergencies (OEs)—acute, life-threatening complications that require immediate intervention. Although Kenya has advanced in decentralising cancer care through regional centres and expanding access to chemotherapy, radiotherapy and palliative care, a critical gap persists in the recognition and management of OEs. Conditions such as spinal cord compression, febrile neutropenia, tumour lysis syndrome and superior vena cava obstruction are common but often underdiagnosed or inadequately managed in acute settings. Poor outcomes are largely driven by workforce shortages, weak triage systems, financial toxicity and limited provider training. This paper calls for a national strategy to integrate OEs management into cancer centres and emergency departments through standardised clinical guidelines, capacity building, improved referral networks and inclusion in health insurance coverage. Strengthening infrastructure, workforce education and longitudinal research on OEs patterns will be essential to improving outcomes. A timely, coordinated response to OEs can substantially enhance survival, reduce complications and promote equitable access to life-saving care across Kenya.
- Open Access
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400131
Medical Tourism for Cancer Treatment: Trends, Trajectories, and Perspectives From African Countries
PURPOSE: Cancer continues to be a significant public health concern. Sub-Saharan Africa (SSA) struggles with a lack of proper infrastructure and adequate cancer care workforce. This has led to some countries relying on referrals of cancer care to countries with higher income levels. In some instances, patients refer themselves. Some countries have made it their goal to attract patients from other countries, a term that has been referred to as medical tourism. In this article, we explore the current status of oncology-related medical tourism in SSA. METHODS: This was a cross-sectional study. The study participants included oncologists, surgeons, and any other physicians who take care of patients with cancer. A predesigned questionnaire was distributed through African Organization for Research and Training in Cancer member mailing list and through study team personal contacts and social media. RESULTS: A total of 52 participants from 17 African countries with a 1.6:2 male to female ratio responded to the survey. Most (55.8%) of the respondents were from Eastern African countries. The majority (92%) of study participants reported that they knew patients who referred themselves abroad, whereas 75% referred patients abroad, and the most common (94%) referral destination was India. The most common (93%) reason for referral was perception of a higher quality of care in foreign health institutions. CONCLUSION: The findings suggest the need to improve local health care systems including building trust of the system among general population. The study highlights potential financial toxicity, and it adds to the current emphasis on return of investment on homegrown workforce and cancer treatment infrastructure.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400131
Open AccessMedical Tourism for Cancer Treatment: Trends, Trajectories, and Perspectives From African Countries
PURPOSE: Cancer continues to be a significant public health concern. Sub-Saharan Africa (SSA) struggles with a lack of proper infrastructure and adequate cancer care workforce. This has led to some countries relying on referrals of cancer care to countries with higher income levels. In some instances, patients refer themselves. Some countries have made it their goal to attract patients from other countries, a term that has been referred to as medical tourism. In this article, we explore the current status of oncology-related medical tourism in SSA. METHODS: This was a cross-sectional study. The study participants included oncologists, surgeons, and any other physicians who take care of patients with cancer. A predesigned questionnaire was distributed through African Organization for Research and Training in Cancer member mailing list and through study team personal contacts and social media. RESULTS: A total of 52 participants from 17 African countries with a 1.6:2 male to female ratio responded to the survey. Most (55.8%) of the respondents were from Eastern African countries. The majority (92%) of study participants reported that they knew patients who referred themselves abroad, whereas 75% referred patients abroad, and the most common (94%) referral destination was India. The most common (93%) reason for referral was perception of a higher quality of care in foreign health institutions. CONCLUSION: The findings suggest the need to improve local health care systems including building trust of the system among general population. The study highlights potential financial toxicity, and it adds to the current emphasis on return of investment on homegrown workforce and cancer treatment infrastructure.
- 1 November 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400471
Diversity and Inclusivity Considerations Are Key When Choosing a Global Oncology Conference Location
We propose equity in representation on who hosts cancer related conferences! It's time for Low and middle income to also rent their academic spaces!, this unfortunately is one of the ways to sort the visa injustices for cancer care providers in LMICs
- 1 November 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400471
Diversity and Inclusivity Considerations Are Key When Choosing a Global Oncology Conference Location
We propose equity in representation on who hosts cancer related conferences! It's time for Low and middle income to also rent their academic spaces!, this unfortunately is one of the ways to sort the visa injustices for cancer care providers in LMICs
- 1 July 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400167
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
PURPOSE: Conflicts of interest (COIs) between oncologists and industry might considerably influence how the presentation of the research results is delivered, ultimately affecting clinical decisions and policy-making. Although there are many regulations on reporting COI in high-income countries (HICs), little is known about their reporting in low- and middle-income countries (LMICs). Oncology Transparency Under Scrutiny and Tracking (ONCOTRUST-1) is a pilot global survey to explore the knowledge and perceptions of oncologists regarding COI. MATERIALS AND METHODS: We designed an online 27-question–based survey in the English language to explore the perceptions and knowledge of oncologists regarding COI, with an emphasis on LMICs. Descriptive statistics and the Consensus-Based Checklist for Reporting of Survey Studies guidelines were used to report the findings. RESULTS: ONCOTRUST-1 surveyed 200 oncologists, 70.9% of them practicing in LMICs. Median age of the respondents was 36 (range, 26-84) years; 47.5% of them were women. Of the respondents, 40.5% reported weekly visits by pharmaceutical representatives to their institutions. Regarding oncologists' perceptions of COI that require disclosure, direct financial benefits, such as honoraria, ranked highest (58.5%), followed by gifts from pharmaceutical representatives (50%) and travel grants for attending conferences (44.5%). By contrast, personal or institutional research funding, sample drugs, consulting or advisory board, expert testimony, and food and beverage funded by pharmaceutical industry were less frequently considered as COI. Moreover, only 24% of surveyed oncologists could correctly categorize all situations representing a COI. CONCLUSION: These findings underscore the importance of clear guidelines, education, and transparency in reporting COI in oncology. This hypothesis-generating pilot survey provided the rationale for ONCOTRUST-2 study, which will compare perceptions of COI among oncologists in LMICs and HICs.
- 1 July 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400167
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
PURPOSE: Conflicts of interest (COIs) between oncologists and industry might considerably influence how the presentation of the research results is delivered, ultimately affecting clinical decisions and policy-making. Although there are many regulations on reporting COI in high-income countries (HICs), little is known about their reporting in low- and middle-income countries (LMICs). Oncology Transparency Under Scrutiny and Tracking (ONCOTRUST-1) is a pilot global survey to explore the knowledge and perceptions of oncologists regarding COI. MATERIALS AND METHODS: We designed an online 27-question–based survey in the English language to explore the perceptions and knowledge of oncologists regarding COI, with an emphasis on LMICs. Descriptive statistics and the Consensus-Based Checklist for Reporting of Survey Studies guidelines were used to report the findings. RESULTS: ONCOTRUST-1 surveyed 200 oncologists, 70.9% of them practicing in LMICs. Median age of the respondents was 36 (range, 26-84) years; 47.5% of them were women. Of the respondents, 40.5% reported weekly visits by pharmaceutical representatives to their institutions. Regarding oncologists' perceptions of COI that require disclosure, direct financial benefits, such as honoraria, ranked highest (58.5%), followed by gifts from pharmaceutical representatives (50%) and travel grants for attending conferences (44.5%). By contrast, personal or institutional research funding, sample drugs, consulting or advisory board, expert testimony, and food and beverage funded by pharmaceutical industry were less frequently considered as COI. Moreover, only 24% of surveyed oncologists could correctly categorize all situations representing a COI. CONCLUSION: These findings underscore the importance of clear guidelines, education, and transparency in reporting COI in oncology. This hypothesis-generating pilot survey provided the rationale for ONCOTRUST-2 study, which will compare perceptions of COI among oncologists in LMICs and HICs.